I'm growing in the spikes
Release time:
2020-08-14
I grew up in peak
■ Jinxi Factory Operation Ming
unconsciously. It has been more than half a year since I graduated from Jinxi Pharmaceutical Factory. Under the careful care and guidance of leaders and colleagues, I not only have a general understanding of the positions and processes of the comprehensive preparation workshop, but also have a deeper understanding of the peak.
When I first arrived in the factory, I was a little depressed about being assigned to work in the workshop. I especially didn't understand why a person with a college diploma wanted to work in the workshop. According to my thoughts at the time, college students should work in a quiet and elegant office. At that time, I even had the idea of resigning. However, after working in the workshop for a week, I found out how ridiculous my idea was-if the theoretical knowledge learned in the university was not applied to the actual production process, it was completely no different from that on paper. Besides, the actual production in the workshop will face many situations, and it is not possible to follow the script with a production process description. With these understandings, my previous unhappiness disappeared and I devoted myself to the work of the workshop.
Fortunately, the old employees are very friendly to me as a newcomer and enthusiastically answer my questions when they encounter problems at work. On several occasions, due to my lack of understanding of machines and crafts, the masters explained it to me once or twice, but they still couldn't understand it. They patiently explained it to me in more detail until I understood it. It is my luck to work with such predecessors as soon as I entered the society. They are also a valuable asset of the peak. It is countless peak employees like them that have created the powerful peak now.
For more than half a year, I have mainly worked in three positions of granulation, tabletting and aluminum-plastic. I have also been to several positions of dropping pills. Among them, I have stayed in the position of granulation for the longest time and have the deepest understanding of the process of this position. I am familiar with the raw materials and auxiliary materials of various drugs, that is, the main drugs, fillers, diluents, disintegrants, lubricants and adhesives of various drugs, as well as their role in the granulation process, have a detailed understanding. The tabletting post shall press the prepared qualified granules into tablets according to the process requirements, and shall always pay attention to adjusting the pressure of the machine and the filling and punching distance of the two punts, so as to solve the problems of lobes, loose pieces, sticking and punching that may occur in time. Aluminum plastic is to pack the pressed tablets with aluminum plastic plate.
After more than half a year's workshop work, I deeply realize that theoretical study is the basis of business practice, and good professional quality is the basis of doing a good job. For college students who have just entered the society, it is very important to master solid professional knowledge. In the repeated work, they should not only maintain the quality and efficiency of the work, but also have the spirit of innovation. I firmly believe that with continuous hard work, I will definitely become an excellent peak employee and truly integrate into the peak group.
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page